Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Q Doctor aims at changing the NHS care delivery with the help of video consulting to benefit patients and clinicians. The company is focusing on delivering a model that keeps modernised NHS care free of charge for the patients. The video solution plugs NHS clinicians to the existing NHS infrastructure and allows them to connect to the NHS patients digitally. With the proceeds, Q Doctor will fulfil its strategy for 2020. It will deploy the funds into labour, development, operations, marketing, and contingency funds.
days to go:
Expired
investment:
£1,386,200
Tech Will Save Us is a company that specialises in making STEAM (Science, Technology, Engineering, Art, and Math) kits for children in the 4-6, 7-10 and 11+ age categories. The company has created a home learning system that enables kids to learn about the world through technology and play. There are three core components to its home learning system: A Digital platform, Physical Experiences and Subscriptions through which the company has helped over 1 million kids build & create. For its ingenuity, the company received the 2019 Good Housekeeping Best Toy Award for Electro Guitar and the Design of the Year Nomination by the London Design Museum. It also collaborated with the BBC to develop The BBC micro: bit., a pocket-sized computer designed for kids to invent with which, in turn, was given to one million kids and is now used in over 40 countries. Its first coding product, Gamer Kit was launched at WIRED's 1st Next Gen conference amidst positive feedback. The company will use 15% of the proceeds in Technology and Research & Development, 25% for marketing, and 60% for working capital and team building.
days to go:
Expired
investment:
£843,940
Nanusens is the manufacturer of small sensor chips that are mainly used in smartphones and earbuds. Its integrated circuits with built-in nano-sensors are reliable, better performing and have a lower cost. Nanusens' patent-pending technology uses an already existing standard manufacturing process known as CMOS, and do not have any mechanical moving parts inside, thereby creating more valuable space within the devices that can be used for other components. This company's first target is the mobile phone industry, which approximately sees 1.5 billion smartphones sold per year, then it has added another growing target market, earbuds. The earbuds are sold mainly by the same companies but require even smaller chips than currently available which Nanusens believe that it can do much better than its competitors along with providing for other future requirements.
days to go:
Expired
investment:
£557,290
Stasher is a company that operates an online platform facilitating luggage storage by connecting travelers with local hotels and shops. Available via their website and app, Stasher offers secure and affordable luggage storage options, benefiting both travelers and local businesses, with a mission to enhance travel experiences across a global network of over 600 cities and 75 countries.
days to go:
Expired
investment:
£568,864
Reset Paris offers a wide range of high-end wellness services including spas, massage, sports and therapy classes. These services are delivered by highly qualified and experienced professionals with a holistic approach. Workshops based on matters like stress-relief, nutrition, focus, memory and sleep are also provided right at the office. The company has recruited a team of freelance professionals and tested their performance with B2B and B2C customers, developed a CRM platform and started collective classes with exceptional feedback. Reset is well-positioned to grow by selling health weeks to companies and increase its visibility through digital marketing.
days to go:
Expired
investment:
£111,430
Aardvark is a company that manufactures dry kibbles for dogs and cats using insects as the source of protein. It has partnered with VC backed insect farm NextProtein. The company claims that its products meet the nutritional needs of pets while creating a smaller environmental footprint than pet food that uses animal meat. It also asserts that insect protein is endorsed by the British Veterinary Association. The company has developed its kibbles to be grain-free, consist of seaweed and other natural ingredients with no fillers. The UK pet food market is poised to grow to £2.9 billion in 2020, and the company aims to be a sustainable manufacturer in this segment. The company requires investment to assist in manufacturing its first batch of pet food, help market its products to pet owners across the UK, and expand into Europe by 2021 and the U.S by 2024.
days to go:
Expired
investment:
£300,290
